share_log

TD Cowen Maintains Outperform on Milestone Pharmaceuticals, Lowers Price Target to $9

Benzinga ·  Dec 27, 2023 08:41

TD Cowen maintains Milestone Pharmaceuticals (NASDAQ:MIST) with a Outperform and lowers the price target from $17 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment